2024 Q4 Form 10-Q Financial Statement

#000103405424000012 Filed on November 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $667.6M
YoY Change -2.19%
Cost Of Revenue $150.3M
YoY Change 0.38%
Gross Profit $517.3M
YoY Change -2.91%
Gross Profit Margin 77.48%
Selling, General & Admin $60.09M
YoY Change -7.3%
% of Gross Profit 11.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $63.51M
YoY Change -6.87%
% of Gross Profit 12.28%
Operating Expenses $123.6M
YoY Change 90.68%
Operating Profit $393.7M
YoY Change 58.35%
Interest Expense -$101.1M
YoY Change -5.61%
% of Operating Profit -25.68%
Other Income/Expense, Net $23.70M
YoY Change -115.25%
Pretax Income $298.2M
YoY Change 219.89%
Income Tax $42.32M
% Of Pretax Income 14.19%
Net Earnings $258.5M
YoY Change 195.74%
Net Earnings / Revenue 38.73%
Basic Earnings Per Share $2.41
Diluted Earnings Per Share $2.40
COMMON SHARES
Basic Shares Outstanding 107.5M 107.5M
Diluted Shares Outstanding 107.9M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $186.3M
YoY Change -2.95%
Cash & Equivalents $186.3M
Short-Term Investments $16.25M
Other Short-Term Assets $128.2M
YoY Change 514.71%
Inventory
Prepaid Expenses
Receivables $135.8M
Other Receivables $0.00
Total Short-Term Assets $450.3M
YoY Change -2.11%
LONG-TERM ASSETS
Property, Plant & Equipment $6.486B
YoY Change 140.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $26.59M
YoY Change -16.92%
Other Assets $772.9M
YoY Change -8.55%
Total Long-Term Assets $9.751B
YoY Change -1.24%
TOTAL ASSETS
Total Short-Term Assets $450.3M
Total Long-Term Assets $9.751B
Total Assets $10.20B
YoY Change -1.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $54.44M
YoY Change 16.79%
Accrued Expenses $392.3M
YoY Change 323.22%
Deferred Revenue $2.792M
YoY Change -72.04%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $23.00M
YoY Change -4.17%
Total Short-Term Liabilities $667.8M
YoY Change 0.71%
LONG-TERM LIABILITIES
Long-Term Debt $12.30B
YoY Change -1.56%
Other Long-Term Liabilities $2.363B
YoY Change 611.31%
Total Long-Term Liabilities $14.66B
YoY Change -0.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $667.8M
Total Long-Term Liabilities $14.66B
Total Liabilities $15.38B
YoY Change -0.58%
SHAREHOLDERS EQUITY
Retained Earnings -$7.394B
YoY Change -0.38%
Common Stock $1.075M
YoY Change -0.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.175B
YoY Change
Total Liabilities & Shareholders Equity $10.20B
YoY Change -1.28%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $258.5M
YoY Change 195.74%
Depreciation, Depletion And Amortization $63.51M
YoY Change -6.87%
Cash From Operating Activities $304.7M
YoY Change -2.88%
INVESTING ACTIVITIES
Capital Expenditures $64.76M
YoY Change 5.47%
Acquisitions $207.4M
YoY Change 290.46%
Other Investing Activities -$209.1M
YoY Change 396.78%
Cash From Investing Activities -$273.9M
YoY Change 164.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -65.91M
YoY Change -71.44%
NET CHANGE
Cash From Operating Activities 304.7M
Cash From Investing Activities -273.9M
Cash From Financing Activities -65.91M
Net Change In Cash -35.16M
YoY Change 69.87%
FREE CASH FLOW
Cash From Operating Activities $304.7M
Capital Expenditures $64.76M
Free Cash Flow $239.9M
YoY Change -4.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 sbac Cash Interest Expense
CashInterestExpense
99322000
CY2023Q3 sbac Noncash Interest Expense
NoncashInterestExpense
7898000
sbac Cash Interest Expense
CashInterestExpense
289632000
sbac Noncash Interest Expense
NoncashInterestExpense
22715000
sbac Cash Interest Expense
CashInterestExpense
301835000
sbac Noncash Interest Expense
NoncashInterestExpense
29655000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001034054
us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
CY2024Q3 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
CY2024Q4 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16853
dei Entity Registrant Name
EntityRegistrantName
SBA COMMUNICATIONS CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0716501
dei Entity Address Address Line1
EntityAddressAddressLine1
8051 Congress Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33487
dei City Area Code
CityAreaCode
561
dei Local Phone Number
LocalPhoneNumber
995-7670
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
SBAC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
107522616
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
186339000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
208547000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
61019000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
38129000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
111018000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
182746000
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
24742000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
16252000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
67149000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
38593000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
450267000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
484267000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2783921000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2711719000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2492360000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2455597000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2322890000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2240781000
CY2024Q3 sbac Acquired And Other Right Of Use Assets Net
AcquiredAndOtherRightOfUseAssetsNet
1379281000
CY2023Q4 sbac Acquired And Other Right Of Use Assets Net
AcquiredAndOtherRightOfUseAssetsNet
1473601000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
772944000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
812476000
CY2024Q3 us-gaap Assets
Assets
10201663000
CY2023Q4 us-gaap Assets
Assets
10178441000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
54438000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
42202000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
89312000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92622000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
23000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
643145000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
183978000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
235668000
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
32088000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
57496000
CY2024Q3 sbac Lease Liability Current
LeaseLiabilityCurrent
270922000
CY2023Q4 sbac Lease Liability Current
LeaseLiabilityCurrent
273464000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14105000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18662000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
667843000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1363259000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12296479000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11681170000
CY2024Q3 sbac Lease Liability Noncurrent
LeaseLiabilityNoncurrent
1930943000
CY2023Q4 sbac Lease Liability Noncurrent
LeaseLiabilityNoncurrent
1865686000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
432158000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
404161000
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
14659580000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
13951017000
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
49092000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
35047000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107506000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107506000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
108050000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
108050000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1075000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1080000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2941520000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2894060000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7393799000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7450824000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-723648000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-615198000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-5174852000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5170882000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10201663000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10178441000
CY2024Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
625697000
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
637440000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1880430000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1880851000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41898000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45104000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105504000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
155709000
CY2024Q3 us-gaap Revenues
Revenues
667595000
CY2023Q3 us-gaap Revenues
Revenues
682544000
us-gaap Revenues
Revenues
1985934000
us-gaap Revenues
Revenues
2036560000
CY2024Q3 sbac Cost Of Goods Sold Direct Operating Lease
CostOfGoodsSoldDirectOperatingLease
117948000
CY2023Q3 sbac Cost Of Goods Sold Direct Operating Lease
CostOfGoodsSoldDirectOperatingLease
118277000
sbac Cost Of Goods Sold Direct Operating Lease
CostOfGoodsSoldDirectOperatingLease
346893000
sbac Cost Of Goods Sold Direct Operating Lease
CostOfGoodsSoldDirectOperatingLease
353411000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32391000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31493000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
82705000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
114914000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
60087000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64821000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
191161000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
200412000
CY2024Q3 sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
5388000
CY2023Q3 sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
5612000
sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
19379000
sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
16622000
CY2024Q3 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
12670000
CY2023Q3 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
33063000
sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
87928000
sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
92320000
CY2024Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
63515000
CY2023Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
180674000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
204444000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
544909000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
291999000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
433940000
us-gaap Costs And Expenses
CostsAndExpenses
932510000
us-gaap Costs And Expenses
CostsAndExpenses
1322588000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
375596000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
248604000
us-gaap Operating Income Loss
OperatingIncomeLoss
1053424000
us-gaap Operating Income Loss
OperatingIncomeLoss
713972000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
6999000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
5266000
us-gaap Investment Income Interest
InvestmentIncomeInterest
21359000
us-gaap Investment Income Interest
InvestmentIncomeInterest
12765000
CY2024Q3 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
95711000
CY2023Q3 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
99322000
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
289632000
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
301835000
CY2024Q3 us-gaap Paid In Kind Interest
PaidInKindInterest
7192000
CY2023Q3 us-gaap Paid In Kind Interest
PaidInKindInterest
7898000
us-gaap Paid In Kind Interest
PaidInKindInterest
22715000
us-gaap Paid In Kind Interest
PaidInKindInterest
29655000
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5185000
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5097000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
15405000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
15129000
sbac Gain Loss On Extinguishment Of Debt Including Interest Expense
GainLossOnExtinguishmentOfDebtIncludingInterestExpense
-4428000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23700000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-48330000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-125811000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29961000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-77389000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-155381000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-436632000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-303893000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
298207000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
93223000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
616792000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
410079000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42316000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7861000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46906000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22192000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
255891000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
85362000
us-gaap Profit Loss
ProfitLoss
569886000
us-gaap Profit Loss
ProfitLoss
387887000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2643000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2057000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6020000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4397000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
258534000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
87419000
us-gaap Net Income Loss
NetIncomeLoss
575906000
us-gaap Net Income Loss
NetIncomeLoss
392284000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.41
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.62
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.40
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.60
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107486000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108373000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107683000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108288000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107922000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108891000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108072000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109017000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
255891000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
85362000
us-gaap Profit Loss
ProfitLoss
569886000
us-gaap Profit Loss
ProfitLoss
387887000
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-45034000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-9489000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-42404000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-16561000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22827000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-29688000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-66708000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11867000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
233684000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
46185000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
460774000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
383193000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2980000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2499000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-6682000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-5296000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
236664000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
48684000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
467456000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
388489000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5316741000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
258534000
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5715000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16728000
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-45034000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
23164000
CY2024Q3 us-gaap Dividends
Dividends
105963000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-11255000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-5174852000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5170882000
us-gaap Net Income Loss
NetIncomeLoss
575906000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8907000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57754000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-42404000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
200019000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-66046000
us-gaap Dividends
Dividends
318871000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-19197000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-5174852000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-5092330000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
87419000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1655000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21787000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-9489000
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
53652000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-29246000
CY2023Q3 us-gaap Dividends
Dividends
92657000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
27000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5166486000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5276315000
us-gaap Net Income Loss
NetIncomeLoss
392284000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-6414000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
67113000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-16561000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
53652000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
12766000
us-gaap Dividends
Dividends
278299000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-7408000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5166486000
us-gaap Profit Loss
ProfitLoss
569886000
us-gaap Profit Loss
ProfitLoss
387887000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
204444000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
544909000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-119526000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
38752000
us-gaap Share Based Compensation
ShareBasedCompensation
56439000
us-gaap Share Based Compensation
ShareBasedCompensation
65830000
sbac Noncash Asset Impairment And Decommission Costs
NoncashAssetImpairmentAndDecommissionCosts
73959000
sbac Noncash Asset Impairment And Decommission Costs
NoncashAssetImpairmentAndDecommissionCosts
81067000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4428000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17053000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1462000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-48875000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-61331000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-53280000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-58673000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16998000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
23501000
sbac Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
101070000
sbac Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
111310000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6576000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-18257000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
24838000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
23767000
sbac Increase Decrease In Long Term Lease Liability
IncreaseDecreaseInLongTermLeaseLiability
-109074000
sbac Increase Decrease In Long Term Lease Liability
IncreaseDecreaseInLongTermLeaseLiability
-103815000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-66777000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
10329000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1024697000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1111782000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
268409000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
92851000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
172600000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
173976000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1204628000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1005143000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1179250000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1005003000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
14033000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
94909000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-480420000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-361876000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
370000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
190000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
390000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
540000000
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2274815000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
2279500000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
18000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
200019000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
53652000
us-gaap Payments Of Dividends
PaymentsOfDividends
318808000
us-gaap Payments Of Dividends
PaymentsOfDividends
278201000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
27144000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
21058000
sbac Payment Stock Option Net Share Settlements
PaymentStockOptionNetShareSettlements
18187000
sbac Payment Stock Option Net Share Settlements
PaymentStockOptionNetShareSettlements
27472000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
707000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
603000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-533848000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-705664000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9883000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1441000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
546000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
42801000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250946000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189283000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
251492000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232084000
us-gaap Interest Paid Net
InterestPaidNet
314700000
us-gaap Interest Paid Net
InterestPaidNet
325799000
us-gaap Income Taxes Paid
IncomeTaxesPaid
25978000
us-gaap Income Taxes Paid
IncomeTaxesPaid
20290000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
44256000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
46909000
sbac Operating Lease Modifications And Reassessments
OperatingLeaseModificationsAndReassessments
214108000
sbac Operating Lease Modifications And Reassessments
OperatingLeaseModificationsAndReassessments
15680000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
154000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1954000
us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 5pt;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The significant estimates made by management relate to the allowance for doubtful accounts, the costs and revenue relating to the Company’s construction contracts, stock-based compensation assumptions, valuation allowance related to deferred tax assets, fair value of long-lived assets, the useful lives of towers and intangible assets, anticipated property tax assessments, incremental borrowing rate for lease accounting, fair value of investments, and asset retirement obligations. Management develops estimates based on historical experience and on various assumptions about the future that are believed to be reasonable based on the information available. These estimates ultimately may differ from actual results and such differences could be material.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 5pt;text-indent: 0.50in;"><span id="_Hlk163735449" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the first quarter of 2024, the Company completed its assessment on the remaining estimated useful lives of its towers and intangible assets. The Company concluded through its assessment that, for U.S. GAAP purposes, it should modify its current estimates for asset lives based on its historical operating experience and the findings obtained by its independent consultant. The Company previously depreciated its towers on a straight-line basis over the shorter of the (i) term of the underlying ground lease (including renewal options) taking into account residual value or (ii) estimated useful life of a tower, which the Company had historically estimated to be </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">15</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years. Based on its assessment, the Company revised the estimated useful lives of its towers and certain related intangible assets (which are amortized on a similar basis to its tower assets, as their useful lives correlate to the useful life of the towers) from </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">15</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years to </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years, effective January 1, 2024. The Company accounted for the change in estimated useful lives as a change in estimate under ASC 250 “Accounting Changes and Error Corrections.” The impact of the change in estimate was accounted for prospectively effective January 1, 2024, resulting in a reduction in depreciation and amortization expense of approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">103.0</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million ($</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">93.3</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million after tax, or an increase of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.86</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per diluted share) and $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">308.5</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million ($</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">279.2</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million after tax, or an increase of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2.58</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per diluted share) for the three and nine months ended September 30, 2024, respectively. This change in useful lives is expected to reduce depreciation and amortization expense by approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">411.5</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million ($</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">372.5</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million after tax, or an increase of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3.45</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per diluted share) for the year ended December 31, 2024.</span></p>
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
16200000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-31200000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-78500000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
24100000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
132100000
CY2024Q3 us-gaap Intercompany Foreign Currency Balance Amount
IntercompanyForeignCurrencyBalanceAmount
1200000000
CY2023Q4 us-gaap Intercompany Foreign Currency Balance Amount
IntercompanyForeignCurrencyBalanceAmount
1300000000
CY2024Q3 sbac Impairment Of Long Lived Assets Held For Use Additions
ImpairmentOfLongLivedAssetsHeldForUseAdditions
8920000
CY2023Q3 sbac Impairment Of Long Lived Assets Held For Use Additions
ImpairmentOfLongLivedAssetsHeldForUseAdditions
27676000
sbac Impairment Of Long Lived Assets Held For Use Additions
ImpairmentOfLongLivedAssetsHeldForUseAdditions
61964000
sbac Impairment Of Long Lived Assets Held For Use Additions
ImpairmentOfLongLivedAssetsHeldForUseAdditions
74372000
CY2024Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
698000
CY2023Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1619000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
12242000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
4451000
CY2024Q3 sbac Other Asset Impairment Charges Including Third Pary Decommission Costs
OtherAssetImpairmentChargesIncludingThirdParyDecommissionCosts
3052000
CY2023Q3 sbac Other Asset Impairment Charges Including Third Pary Decommission Costs
OtherAssetImpairmentChargesIncludingThirdParyDecommissionCosts
3768000
sbac Other Asset Impairment Charges Including Third Pary Decommission Costs
OtherAssetImpairmentChargesIncludingThirdParyDecommissionCosts
13722000
sbac Other Asset Impairment Charges Including Third Pary Decommission Costs
OtherAssetImpairmentChargesIncludingThirdParyDecommissionCosts
13497000
CY2024Q3 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
12670000
CY2023Q3 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
33063000
sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
87928000
sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
92320000
CY2024Q3 us-gaap Long Term Investments
LongTermInvestments
26600000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
24500000
sbac Cost Method Invesment Impairment Loss
CostMethodInvesmentImpairmentLoss
0
CY2023Q3 sbac Cost Method Invesment Impairment Loss
CostMethodInvesmentImpairmentLoss
0
sbac Cost Method Invesment Impairment Loss
CostMethodInvesmentImpairmentLoss
0
CY2024Q3 sbac Cost Method Invesment Impairment Loss
CostMethodInvesmentImpairmentLoss
0
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
16200000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
1000000.0
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1200000000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1000000.0
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
186339000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
208547000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
251492000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250946000
CY2024Q3 us-gaap Restricted Investments
RestrictedInvestments
42200000
CY2023Q4 us-gaap Restricted Investments
RestrictedInvestments
42000000.0
CY2023Q4 sbac Collateral For Surety Payment And Performance Bonds
CollateralForSuretyPaymentAndPerformanceBonds
0
CY2024Q3 sbac Collateral For Surety Payment And Performance Bonds
CollateralForSuretyPaymentAndPerformanceBonds
0
CY2024Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
58392000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
98674000
CY2024Q3 sbac Contract With Customer Estimated Earnings
ContractWithCustomerEstimatedEarnings
25381000
CY2023Q4 sbac Contract With Customer Estimated Earnings
ContractWithCustomerEstimatedEarnings
64589000
CY2024Q3 sbac Contract With Customer Billing To Date
ContractWithCustomerBillingToDate
61823000
CY2023Q4 sbac Contract With Customer Billing To Date
ContractWithCustomerBillingToDate
152608000
CY2024Q3 sbac Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
21950000
CY2023Q4 sbac Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
10655000
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
24742000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
16252000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2792000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5597000
CY2024Q3 sbac Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
21950000
CY2023Q4 sbac Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
10655000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
16245000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
1046000
CY2024Q3 sbac Prepaid Real Estate Taxes
PrepaidRealEstateTaxes
5099000
CY2023Q4 sbac Prepaid Real Estate Taxes
PrepaidRealEstateTaxes
3522000
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
6996000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
2102000
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
3058000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1522000
CY2024Q3 us-gaap Prepaid Taxes
PrepaidTaxes
11870000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
9064000
CY2024Q3 sbac Prepaid Rent Current
PrepaidRentCurrent
2911000
CY2023Q4 sbac Prepaid Rent Current
PrepaidRentCurrent
3712000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
20970000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17625000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
67149000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
38593000
CY2024Q3 us-gaap Deferred Rent Receivables Net Noncurrent
DeferredRentReceivablesNetNoncurrent
420783000
CY2023Q4 us-gaap Deferred Rent Receivables Net Noncurrent
DeferredRentReceivablesNetNoncurrent
415100000
CY2024Q3 us-gaap Derivative Assets
DerivativeAssets
44934000
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
104674000
CY2024Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
164775000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
148104000
CY2024Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8690000
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8713000
CY2024Q3 us-gaap Long Term Investments
LongTermInvestments
26587000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
24540000
CY2024Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
47523000
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
43872000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
772944000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
812476000
CY2024Q3 sbac Towers And Related Intangible Assets Acquisitions
TowersAndRelatedIntangibleAssetsAcquisitions
196659000
CY2023Q3 sbac Towers And Related Intangible Assets Acquisitions
TowersAndRelatedIntangibleAssetsAcquisitions
41060000
sbac Towers And Related Intangible Assets Acquisitions
TowersAndRelatedIntangibleAssetsAcquisitions
234853000
sbac Towers And Related Intangible Assets Acquisitions
TowersAndRelatedIntangibleAssetsAcquisitions
63411000
CY2024Q3 sbac Ground Lease Land Purchases
GroundLeaseLandPurchases
10728000
CY2023Q3 sbac Ground Lease Land Purchases
GroundLeaseLandPurchases
12054000
sbac Ground Lease Land Purchases
GroundLeaseLandPurchases
33556000
sbac Ground Lease Land Purchases
GroundLeaseLandPurchases
29440000
CY2024Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
207387000
CY2023Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
53114000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
268409000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
92851000
CY2024Q3 sbac Ground Lease Extensions
GroundLeaseExtensions
7700000
CY2023Q3 sbac Ground Lease Extensions
GroundLeaseExtensions
6700000
sbac Ground Lease Extensions
GroundLeaseExtensions
17000000.0
sbac Ground Lease Extensions
GroundLeaseExtensions
15000000.0
CY2024Q3 sbac Performance Targets Maximum Potential Obligation
PerformanceTargetsMaximumPotentialObligation
13500000
CY2023Q4 sbac Performance Targets Maximum Potential Obligation
PerformanceTargetsMaximumPotentialObligation
17900000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7068382000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6959501000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4284461000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4247782000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2783921000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2711719000
CY2024Q3 us-gaap Depreciation
Depreciation
25800000
CY2023Q3 us-gaap Depreciation
Depreciation
68200000
us-gaap Depreciation
Depreciation
89400000
us-gaap Depreciation
Depreciation
206600000
CY2024Q3 sbac Capital Expenditure Accrual Current
CapitalExpenditureAccrualCurrent
12400000
CY2023Q4 sbac Capital Expenditure Accrual Current
CapitalExpenditureAccrualCurrent
6500000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7213807000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4721447000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2492360000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7179789000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4724192000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2455597000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26400000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79800000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
303500000
CY2024Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
23989000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
25630000
CY2024Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
9607000
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
7149000
CY2024Q3 sbac Capital Expenditure Accrual Current
CapitalExpenditureAccrualCurrent
12415000
CY2023Q4 sbac Capital Expenditure Accrual Current
CapitalExpenditureAccrualCurrent
6477000
CY2024Q3 sbac Accrued Holdbacks
AccruedHoldbacks
11682000
CY2023Q4 sbac Accrued Holdbacks
AccruedHoldbacks
16100000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
31619000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37266000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
89312000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92622000
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
12388500000
CY2024Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
11604174000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
12319479000
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
12388000000
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
11480332000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
12324315000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
23000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
643145000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12296479000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11681170000
CY2024Q3 sbac Cash Interest Expense
CashInterestExpense
95711000
CY2024Q3 sbac Noncash Interest Expense
NoncashInterestExpense
7192000
CY2023 sbac Line Of Credit Facility Margin Adjustment
LineOfCreditFacilityMarginAdjustment
0.00050
CY2023 sbac Line Of Credit Facility Commitment Fee Adjustment
LineOfCreditFacilityCommitmentFeeAdjustment
0.00010
CY2023Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
400000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
900000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
400000
CY2023Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
197.75
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
213.85
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
197.75
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
87300000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
200000000.0
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
87300000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1340000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
168.32
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
201000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
134.67
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
197.91
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1137000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
174.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y2M12D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
76424000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1115000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
172.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y1M6D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
76160000
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
22000
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
252.81
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y3M18D
CY2024Q3 sbac Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIntrinsicValue
264000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
16600000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
382300000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q3 us-gaap Revenues
Revenues
667595000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
150339000
CY2024Q3 us-gaap Gross Profit
GrossProfit
517256000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
60087000
CY2024Q3 sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
5388000
CY2024Q3 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
12670000
CY2024Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
63515000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
375596000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-77389000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
298207000
CY2024Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
272297000
CY2023Q3 us-gaap Revenues
Revenues
682544000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
149770000
CY2023Q3 us-gaap Gross Profit
GrossProfit
532774000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64821000
CY2023Q3 sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
5612000
CY2023Q3 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
33063000
CY2023Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
180674000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
248604000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-155381000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
93223000
CY2023Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
115430000
us-gaap Revenues
Revenues
1985934000
us-gaap Cost Of Revenue
CostOfRevenue
429598000
us-gaap Gross Profit
GrossProfit
1556336000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
191161000
sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
19379000
sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
87928000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
204444000
us-gaap Operating Income Loss
OperatingIncomeLoss
1053424000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-436632000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
616792000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
441163000
us-gaap Revenues
Revenues
2036560000
us-gaap Cost Of Revenue
CostOfRevenue
468325000
us-gaap Gross Profit
GrossProfit
1568235000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
200412000
sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
16622000
sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
92320000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
544909000
us-gaap Operating Income Loss
OperatingIncomeLoss
713972000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-303893000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
410079000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
268781000
CY2024Q3 us-gaap Assets
Assets
10201663000
CY2023Q4 us-gaap Assets
Assets
10178441000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
258534000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
87419000
us-gaap Net Income Loss
NetIncomeLoss
575906000
us-gaap Net Income Loss
NetIncomeLoss
392284000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107486000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108373000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107683000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108288000
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
436000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
518000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
389000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
729000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107922000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108891000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108072000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109017000
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.41
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.81
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
5.35
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.62
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.40
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.80
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
5.33
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.60
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
35047000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
31735000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6020000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4397000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest
662000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest
899000
sbac Contribution From Joint Venture Partner
ContributionFromJointVenturePartner
1530000
CY2023 sbac Contribution From Joint Venture Partner
ContributionFromJointVenturePartner
1200000
us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
19197000
CY2023 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
7408000
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
49092000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
35047000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001034054-24-000012-index-headers.html Edgar Link pending
0001034054-24-000012-index.html Edgar Link pending
0001034054-24-000012.txt Edgar Link pending
0001034054-24-000012-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbac-20240930.xsd Edgar Link pending
sbac-20240930x10q.htm Edgar Link pending
sbac-20240930xex31_1.htm Edgar Link pending
sbac-20240930xex31_2.htm Edgar Link pending
sbac-20240930xex32_1.htm Edgar Link pending
sbac-20240930xex32_2.htm Edgar Link pending
Show.js Edgar Link pending
sbac-20240930_cal.xml Edgar Link unprocessable
sbac-20240930_def.xml Edgar Link unprocessable
sbac-20240930_lab.xml Edgar Link unprocessable
sbac-20240930_pre.xml Edgar Link unprocessable
sbac-20240930x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable